Target intelligence / Profile preview

Gut microbiota community composition and metabolic function (GM)

Target
GM
Molecular classification
Other
01

Overview

The gut microbiota community composition and metabolic function refers to the vast ecosystem of microorganisms inhabiting the human gastrointestinal tract and their collective biochemical activities. This complex system serves as a critical interface between the host and the environment, performing essential roles in fermenting non-digestible carbohydrates into short-chain fatty acids, synthesizing vitamins, and regulating the development and function of the host immune system (Lynch & Pedersen, 2016, NEJM). Dysbiosis, characterized by a loss of microbial diversity or an overgrowth of pathobionts, is implicated in numerous conditions including Clostridioides difficile infection, inflammatory bowel disease, and metabolic disorders like obesity and type 2 diabetes (Fan & Pedersen, 2021, Nature Reviews Endocrinology). Therapeutic interventions targeting this system range from broad-spectrum antibiotics and fecal microbiota transplants to precision live biotherapeutic products and prebiotics designed to shift the community toward a health-associated state. As a therapeutic target, the gut microbiota presents unique challenges due to its high inter-individual variability and the complex, multi-directional interactions between microbial metabolites and host physiology (Kho & Lal, 2018, Molecules).

Other names
Gut microbiomeIntestinal microbiotaGastrointestinal floraGut commensal communityHuman intestinal microbiome
02

Mechanism of action

Restoration of microbial diversity and ecological balance to suppress pathogens and normalize host metabolic and immune signaling pathways.

03

Biological functions

Nutrient metabolismImmune system modulationPathogen exclusionVitamin synthesisBile acid transformationShort-chain fatty acid production
04

Disease associations

Clostridioides difficile infectionInflammatory bowel diseaseObesityType 2 diabetesIrritable bowel syndromeColorectal cancerNon-alcoholic fatty liver disease
05

Safety considerations

Risk of systemic infectionTransfer of antibiotic resistance genesUnintended long-term metabolic changesVariability in donor-derived material
06

Interacting drugs

SER-109

6 more in the full profile.

07

Biomarkers

Shannon diversity indexFirmicutes/Bacteroidetes ratioFecal butyrate levelsAbundance of Akkermansia muciniphila

Beyond the preview

Go deeper on Gut microbiota community composition and metabolic function (GM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota community composition and metabolic function (GM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call